Literature DB >> 23899676

Challenging issues in tuberculosis in solid organ transplantation.

David J Horne1, Masahiro Narita, Christopher L Spitters, Soumya Parimi, Sherry Dodson, Ajit P Limaye.   

Abstract

Solid organ transplant (SOT) recipients are at risk for opportunistic infections including tuberculosis. Although guidelines on the management of latent tuberculosis and active tuberculosis are available, there remain a number of clinical areas with limited guidance. We discuss challenges in the diagnosis, management, and treatment of latent and active tuberculosis in SOT candidates and recipients who reside in low-tuberculosis-prevalence areas. We discuss the diagnosis of latent tuberculosis in SOT candidates/recipients using tuberculin skin tests and interferon-γ release assays and risk stratification of SOT candidates/recipients that would identify individuals at high risk for latent tuberculosis despite negative test results. Through a careful review of posttransplant tuberculosis cases, we identify a history of treated tuberculosis in SOT recipients as a risk factor for development of posttransplant active tuberculosis. Finally, we include comparisons of recommendations by several large transplant organizations and identify areas for future research.

Entities:  

Keywords:  solid organ transplant; tuberculosis

Mesh:

Year:  2013        PMID: 23899676      PMCID: PMC3805170          DOI: 10.1093/cid/cit488

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  51 in total

1.  Experience with rifabutin replacing rifampin in the treatment of tuberculosis.

Authors:  D J Horne; C Spitters; M Narita
Journal:  Int J Tuberc Lung Dis       Date:  2011-11       Impact factor: 2.373

Review 2.  Protease inhibitor-containing antiretroviral treatment and tuberculosis: can rifabutin fill the breach?

Authors:  A Loeliger; A B Suthar; D Ripin; P Glaziou; M O'Brien; F Renaud-Thery; S Crowley; B Williams; R Ridzon; R Granich; C Gilks
Journal:  Int J Tuberc Lung Dis       Date:  2011-08-03       Impact factor: 2.373

Review 3.  An update on donor-derived disease transmission in organ transplantation.

Authors:  M G Ison; M A Nalesnik
Journal:  Am J Transplant       Date:  2011-03-28       Impact factor: 8.086

4.  Diagnosis and treatment of latent tuberculosis infection in liver transplant recipients in an endemic area.

Authors:  Natividad Benito; Omar Sued; Asunción Moreno; Juan P Horcajada; Julià González; Miquel Navasa; Antoni Rimola
Journal:  Transplantation       Date:  2002-11-27       Impact factor: 4.939

5.  Chest computed tomography is more likely to show latent tuberculosis foci than simple chest radiography in liver transplant candidates.

Authors:  Jiwon Lyu; Sung-Gyu Lee; Shin Hwang; Sang-Oh Lee; Oh-Hyun Cho; Eun Jin Chae; Sang Do Lee; Woo Sung Kim; Dong Soon Kim; Tae Sun Shim
Journal:  Liver Transpl       Date:  2011-08       Impact factor: 5.799

6.  Use of rifabutin for the treatment of a latent tuberculosis infection in a patient after solid organ transplantation.

Authors:  Matthew D Hickey; David J Quan; Peter V Chin-Hong; John P Roberts
Journal:  Liver Transpl       Date:  2013-03-22       Impact factor: 5.799

Review 7.  Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data.

Authors:  Jon-Erik C Holty; Michael K Gould; Laura Meinke; Emmet B Keeffe; Stephen J Ruoss
Journal:  Liver Transpl       Date:  2009-08       Impact factor: 5.799

8.  Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology.

Authors:  José María Aguado; Julián Torre-Cisneros; Jesús Fortún; Natividad Benito; Yolanda Meije; Antonio Doblas; Patricia Muñoz
Journal:  Clin Infect Dis       Date:  2009-05-01       Impact factor: 9.079

9.  Mycobacterial infection in renal transplant recipients.

Authors:  C M Hall; P A Willcox; C R Swanepoel; D Kahn; R Van Zyl Smit
Journal:  Chest       Date:  1994-08       Impact factor: 9.410

10.  Screening of donor and recipient prior to solid organ transplantation.

Authors:  S A Fischer; R K Avery
Journal:  Am J Transplant       Date:  2009-12       Impact factor: 8.086

View more
  14 in total

Review 1.  Disseminated Mycobacterium tuberculosis following renal transplant with alemtuzumab induction.

Authors:  Adam Baghban; Marwan Mikheal Azar; Raffaele Mario Bernardo; Maricar Malinis
Journal:  BMJ Case Rep       Date:  2016-11-16

2.  Tuberculosis after liver transplantation in a large center in New York City: QuantiFERON® -TB Gold-based pre-transplant screening performance and active tuberculosis post-transplant.

Authors:  Jonathan Hand; Keith Sigel; Shirish Huprikar; Camille Hamula; Meena Rana
Journal:  Transpl Infect Dis       Date:  2018-02-19       Impact factor: 2.228

3.  Immunodiagnostic Tests' Predictive Values for Progression to Tuberculosis in Transplant Recipients: A Prospective Cohort Study.

Authors:  Laura Muñoz; Aina Gomila; Susana Casas; José Castellote; Montserrat Arnan; Antoni Rafecas; Miguel Santin
Journal:  Transplant Direct       Date:  2015-04-01

Review 4.  Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infections.

Authors:  Christopher S Kovacs; Christine E Koval; David van Duin; Amanda Guedes de Morais; Blanca E Gonzalez; Robin K Avery; Steven D Mawhorter; Kyle D Brizendine; Eric D Cober; Cyndee Miranda; Rabin K Shrestha; Lucileia Teixeira; Sherif B Mossad
Journal:  World J Transplant       Date:  2014-06-24

5.  Donor-derived tuberculosis after solid organ transplantation in two patients and a staff member.

Authors:  J N Bucher; M B Schoenberg; I Freytag; U Lange; S Hofmann-Thiel; M O Guba; J Werner; A Eder; G Schelling; M Stangl
Journal:  Infection       Date:  2015-10-23       Impact factor: 3.553

Review 6.  Chronic dialysis, NAT2 polymorphisms, and the risk of isoniazid-induced encephalopathy - case report and literature review.

Authors:  Stefan Matei Constantinescu; Benoit Buysschaert; Vincent Haufroid; Franck Broly; Michel Jadoul; Johann Morelle
Journal:  BMC Nephrol       Date:  2017-09-04       Impact factor: 2.388

Review 7.  Tuberculosis in Solid Organ Transplantation.

Authors:  Afshin Mohammad Alizadeh; Majid Marjani; Afshin Moniri; Parvaneh Baghaei; Sayena Jabbehdari; Pedram Javanmard; Payam Tabarsi
Journal:  Tanaffos       Date:  2016

Review 8.  Transplanted lungs and the "white plague": A case-report and review of the literature.

Authors:  Nadim Cassir; Robin Delacroix; Carine Gomez; Véronique Secq; Martine Reynaud-Gaubert; Pascal-Alexandre Thomas; Laurent Papazian; Michel Drancourt
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

Review 9.  Tuberculosis in hematopoietic stem cell transplant recipients.

Authors:  Jéssica Fernandes Ramos; Marjorie Vieira Batista; Silvia Figueiredo Costa
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-11-04       Impact factor: 2.576

10.  Everolimus-induced activation of latent Mycobacterium tuberculosis infection in a patient with metastatic renal cell carcinoma.

Authors:  So-Yeon Jeon; Ho-Young Yhim; Na-Ri Lee; Eun-Kee Song; Jae-Yong Kwak; Chang-Yeol Yim
Journal:  Korean J Intern Med       Date:  2016-02-02       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.